A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.
| Image |  |
|---|---|
| Description | scientific article published on 28 February 2017 |
| Author/s |
author: Sridharan Gururangan Maryam Fouladi Arzu Onar-Thomas Michael D Prados Larry E Kun |
| Publication date | February 28, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |